|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7530 EUR | -1.05% |
|
-0.79% | -28.83% |
| 06-08 | Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy | CI |
| 06-08 | Amoéba secures strategic emergency authorization in Italy |
Company Valuation: Amoéba
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 19.15 | 19.17 | 19.06 | 45.7 | 72.88 | 51.87 | - | - |
| Change | - | 0.11% | -0.55% | 139.79% | 59.46% | -28.83% | - | - |
| Enterprise Value (EV) 1 | 19.15 | 16 | 21.14 | 45.7 | 80.4 | 63.02 | 63.72 | 59.67 |
| Change | - | -16.45% | 32.14% | 116.23% | 75.91% | -21.61% | 1.11% | -6.36% |
| P/E | - | -3.4x | -1.32x | -7.08x | -7.56x | -10x | 75.3x | 7.53x |
| PBR | - | - | - | - | -13.6x | -2.28x | -2.28x | - |
| PEG | - | - | -0.1x | 0.1x | -0.98x | 0.2x | -1x | 0x |
| Capitalization / Revenue | - | - | - | - | - | 10.2x | 3.34x | 1.85x |
| EV / Revenue | - | - | - | - | - | 12.4x | 4.1x | 2.12x |
| EV / EBITDA | - | -3.01x | -1.57x | -9.35x | -13.7x | -27.4x | 18.7x | - |
| EV / EBIT | - | -2.74x | -3.18x | -8.07x | -11.9x | -17.5x | 25x | 5.91x |
| EV / FCF | - | - | -2.27x | -9.56x | -11.6x | -10.7x | 106x | 13.3x |
| FCF Yield | - | - | -44.1% | -10.5% | -8.65% | -9.36% | 0.94% | 7.54% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | -0.25 | -0.29 | -0.13 | -0.14 | -0.075 | 0.01 | 0.1 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 5.1 | 15.55 | 28.1 |
| EBITDA 1 | - | -5.309 | -13.47 | -4.887 | -5.85 | -2.3 | 3.4 | - |
| EBIT 1 | - | -5.843 | -6.638 | -5.663 | -6.784 | -3.6 | 2.55 | 10.1 |
| Net income 1 | -7.817 | -8.023 | -14.3 | -6.592 | -8.303 | -5.2 | 0.55 | 6.8 |
| Net Debt 1 | - | -3.171 | 2.077 | - | 7.516 | 11.15 | 11.85 | 7.8 |
| Reference price 2 | 1.0600 | 0.8500 | 0.3840 | 0.9210 | 1.0580 | 0.7530 | 0.7530 | 0.7530 |
| Nbr of stocks (in thousands) | 18,061 | 22,548 | 49,634 | 49,624 | 68,886 | 68,886 | - | - |
| Announcement Date | 3/31/22 | 3/30/23 | 3/28/24 | 4/17/25 | 2/23/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -10.04x | 12.36x | -27.4x | - | 59.49M | ||
| 13.57x | 1.47x | 7.31x | 1.97% | 3.2B | ||
| 32.72x | - | - | 1.5% | 3.07B | ||
| 21.41x | - | - | 0.17% | 1.92B | ||
| 16.81x | - | - | 2.01% | 1.53B | ||
| 8.89x | - | - | 3.46% | 1.4B | ||
| 12.36x | - | - | 3.9% | 1.39B | ||
| 7.29x | - | - | 6.54% | 1.34B | ||
| 14.6x | - | - | 2.71% | 1.26B | ||
| Average | 13.07x | 6.91x | -10.05x | 2.78% | 1.68B | |
| Weighted average by Cap. | 17.66x | 1.67x | 6.67x | 2.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALMIB Stock
- Valuation Amoéba
Select your edition
All financial news and data tailored to specific country editions
















